| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |